In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.00% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,240.65 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.



.jpg)



